Bayer major shareholder Harris backs CEO to focus on internal restructuring

Business and Financehealthy

Reuters exclusive report Bayer’s top shareholder Harris Associates has strongly backed the drugmaker’s decision to pause efforts to break up the diversified group, giving the embattled chief executive some breathing room.

market impact

The news caused Bayer’s share price to narrow its losses sharply. The group’s shares closed down 0.9% after the comments, after falling 6.3% earlier in the session.

Article tags

Topics of interest: Business and Financehealthy

type: Reuters Best

department: Business and FinancePharmaceuticals and Healthcare

area: Europe

Winning type: exclusivity

Story type: exclusive/exclusive report

media type: text

Customer Impact: Important regional stories

Source link

See also  German far-rightists meet to plan 'mass deportations'

By Ali Raza

I am a dedicated and skilled News Content Writer with a passion for delivering accurate and engaging stories to a diverse audience. With a solid background in journalism and a keen eye for detail, I bring a commitment to excellence and a deep understanding of the evolving media landscape.

Leave a Reply

Your email address will not be published. Required fields are marked *